Giobbe C, Piacentino R, Marchino G L, Zaccheo F, Cellura A, Ferrara L, Mazza O, Caccuri D, Condello V, Grio R
Istituto di Ginecologia e Ostetricia, Cattedra A, Università di Torino.
Minerva Ginecol. 1990 Nov;42(11):463-6.
The paper reports the results of a study to assess the contraceptive efficacy of a new triphasic pill (Trinovum - Cilag AG). The pill was administered to 50 women aged between 18 and 41 years for 12 months, giving a total of 600 menstrual cycles. Data confirm the value of this pill which ensures excellent contraceptive efficacy and is well tolerated by patients with very few adverse effects.
该论文报告了一项评估新型三相避孕药（Trinovum - 西拉格公司）避孕效果的研究结果。该避孕药给予了50名年龄在18至41岁之间的女性服用，为期12个月，共计600个月经周期。数据证实了这种避孕药的价值，它确保了出色的避孕效果，并且患者耐受性良好，副作用极少。
